News
QURE
26.46
-2.00%
-0.54
A Look At uniQure (QURE) Valuation After FDA Setback For Huntington’s Disease Therapy
Simply Wall St · 6h ago
Weekly Report: what happened at QURE last week (0601-0605)?
Weekly Report · 1d ago
Acting FDA head vows to block political interference, Endpoint News says
TipRanks · 5d ago
Watching uniQure; Shares See A Spike In Volume, Endpoints News Reports "Acting FDA Commissioner Pledges To Prevent Political Interference In Rare Disease Meeting"
Benzinga · 5d ago
FDA issues draft guidance to help accelerated cell, gene therapies for patients
TipRanks · 06/02 14:03
A Look At uniQure (QURE) Valuation After Strong Recent Share Price Gains
Simply Wall St · 06/02 00:28
uniQure: Why A Shifting FDA Could Change Everything For AMT-130
Seeking Alpha · 06/01 15:14
Weekly Report: what happened at QURE last week (0525-0529)?
Weekly Report · 06/01 10:01
Replimune, Dell Technologies, NetApp And Other Big Stocks Moving Higher on Friday
Benzinga · 05/29 14:32
A Look At uniQure (QURE) Valuation After AMT-130 Gene Therapy Regulatory Plans And Trial Update
Simply Wall St · 05/25 12:13
Weekly Report: what happened at QURE last week (0518-0522)?
Weekly Report · 05/25 10:04
Is uniQure’s (QURE) AMT-130 UK Push Quietly Rewriting Its Risk Profile and R&D Strategy?
Simply Wall St · 05/24 02:20
Biotech Investors Are Tuning Out the MAHA Chaos -- Heard on the Street
The Wall Street Journal · 05/20 09:30
Weekly Report: what happened at QURE last week (0511-0515)?
Weekly Report · 05/18 10:04
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
TipRanks · 05/12 18:28
'Makary's Time Atop FDA Over, Diamantas Named Acting Commissioner' - Politico
Benzinga · 05/12 16:49
UniQure Q1 Earnings Review: Limited Progress With FDA, But UK Approval In Play
Seeking Alpha · 05/12 14:24
Trump Trade: U.S. plans AI security order without required model tests
TipRanks · 05/11 19:29
Trump approves plan to fire FDA head Marty Makary, CBS reports
TipRanks · 05/11 17:54
'Trump Approves Plan To Fire FDA Commissioner Marty Makary, Sources Say' - CBS
Benzinga · 05/11 16:17
More
Webull provides a variety of real-time QURE stock news. You can receive the latest news about Uniqure through multiple platforms. This information may help you make smarter investment decisions.
About QURE
Uniqure NV is a company based in the Netherlands specialized in gene therapy. It seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. It develops, both internally and through partnerships, a pipeline of gene therapies. It produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing practices, compliant, manufacturing process. AMT-061, the Company’s lead product candidate for patients with hemophilia B, is going through a dosing phase of a pivotal study. AMT-130, the product candidate for patients with Huntington’s disease is in Phase I/II clinical study.